NCT02964234

Empowering Latinas to Obtain Breast Cancer Screenings

Completed NA Results posted Last updated 18 November 2021

What this trial tests

NA trial testing Empowerment in Breastcancer in 145 participants. Completed in 31 August 2021.

Timeline

1 March 2017

Primary endpoint
24 July 2019

31 August 2021

Quick facts

Lead sponsor	University of Illinois at Chicago
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	145
Start date	1 March 2017
Primary completion	24 July 2019
Estimated completion	31 August 2021
Sites	3 locations across United States

Drugs / interventions tested

• Empowerment
• Education

Conditions studied

• Breastcancer — all drugs for Breastcancer →
• Breast Diseases — all drugs for Breast Diseases →

Sponsor

University of Illinois at Chicago

Who can join

Adults 52 to 75, female only, with Breastcancer or Breast Diseases. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants Who Have Obtained Breast Cancer Screening Primary · 6 months

Receipt of mammogram based on medical records and self report within 6 months of baseline survey (Yes or No)

Group	Value	95% CI
Empowerment	49
Education	29

Changes in Psychosocial Facilitators of Screening Survey Measures Secondary · Baseline and 6 months

Total scores/ranges are used. No subscales used. Knowledge - 5 items (Williams et al., 2011). Range for the change scores (baseline to 6-months) is -5 to 5. Higher scores represent a better outcome. Cultural beliefs - Ferrans cultural beliefs scale (Ferrans et al., 2007). Range for the change scores (baseline to 6-months) is -17 to 17. Higher scores represent a worse outcome. Breast cancer-specific self-efficacy - Mammography-Specific Self-Efficacy Scale (Champion, Skinner, \& Menon, 2005). Range for the change scores (baseline to 6-months) is -26 to 26. Higher scores represent a better outc

Knowledge

Group	Value	95% CI
Empowerment	0.98	± 1.60
Education	1.37	± 1.69

Cultural Beliefs

Group	Value	95% CI
Empowerment	-1.36	± 2.94
Education	-2.41	± 3.13

Self-Efficacy

Group	Value	95% CI
Empowerment	1.02	± 4.67
Education	-1.00	± 5.99

Social Norms

Group	Value	95% CI
Empowerment	0.25	± 2.42
Education	0.32	± 2.94

Supportive Network size

Group	Value	95% CI
Empowerment	1.38	± 4.66
Education	5.85	± 2.11

Number of Individuals to Whom Participants Exchanged Information About Breast Cancer Screening. Secondary · 6 months

This was an open-ended questionnaire, based on the Burt Social Network Instrument. Higher numbers represent better outcomes.

Group	Value	95% CI
Empowerment	8.27	± 6.17
Education	5.81	± 12.58

Sponsor's own description

The participatory-based project will quantify the 'added benefit' of an empowerment intervention relative to an education intervention for 150 Latinas on the following outcomes: women's adherence to breast cancer screening guidelines; women's psychosocial facilitators (self-efficacy, norms, support, and knowledge); and women's dissemination of breast health messages throughout their social network. The empowerment intervention will train Latinas in how to discuss breast health with their family and friends and volunteer in local breast health promotion programs. Academic, clinician, and community partners will work together throughout intervention development and evaluation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Shared decision-making for supporting women's decisions about breast cancer screening.
   Riganti P, Ruiz Yanzi MV, Escobar Liquitay CM, Sgarbossa NJ, et al · · 2024 · cited 13× · PMID 38726892 · DOI 10.1002/14651858.cd013822.pub2